Hopstem
About:
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Website: http://www.hopstem.com/
Top Investors: Lilly Asia Ventures, Delta Capital, BioVenture, Hillhouse Ventures, Empower Investment
Description:
Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Total Funding Amount:
$42.9M
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2017-01-01
Contact Email:
info(AT)hopstem.com
Founders:
Jing Fan
Number of Employees:
1-10
Last Funding Date:
2021-10-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai